Inventiva (IVEVF) Beginning Cash Balance (2018 - 2025)
Inventiva (IVEVF) posted Beginning Cash Balance of $112.4 million for Q4 2025, up 2.83% on a QoQ basis from $109.3 million in Q2 2025, and up 290.78% year-over-year from $28.8 million in Q4 2024.
Analysis
Inventiva (IVEVF) Beginning Cash Balance (2018 - 2025) Analysis & Trends
Inventiva has reported Beginning Cash Balance for 8 years, with the latest figure at $112.4 million in Q4 2025.
- On a quarterly basis, Beginning Cash Balance rose 290.78% year-over-year to $112.4 million in Q4 2025; TTM through Dec 2025 was $112.4 million, a 290.78% increase from a year earlier, with the FY2025 full-year figure at $112.4 million, up 290.78% from the prior year.
- Beginning Cash Balance was $112.4 million for Q4 2025 at Inventiva, up from $109.3 million in the prior quarter.
- The five-year high for Beginning Cash Balance was $127.5 million in Q1 2021, with the low at $28.8 million in Q4 2024.
- Average Beginning Cash Balance over 5 years is $92.8 million, with a median of $93.9 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Beginning Cash Balance tumbled 69.31% in 2024, then soared 290.78% in 2025.
- Over 5 years, Beginning Cash Balance stood at $120.9 million in 2021, then dropped by 26.96% to $88.3 million in 2022, then grew by 5.68% to $93.3 million in 2023, then tumbled by 69.18% to $28.8 million in 2024, then jumped by 290.78% to $112.4 million in 2025.
- The last three Beginning Cash Balance figures came in at $112.4 million (Q4 2025), $109.3 million (Q2 2025), and $28.8 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 112.40 Mn |
| Jun 30, 2025 | 109.31 Mn |
| Dec 31, 2024 | 28.76 Mn |
| Jun 30, 2024 | 28.99 Mn |
| Dec 31, 2023 | 93.32 Mn |
| Jun 30, 2023 | 94.45 Mn |
| Dec 31, 2022 | 88.31 Mn |
| Sep 22, 2022 | 90.31 Mn |
| Jun 30, 2022 | 92.36 Mn |
| Dec 31, 2021 | 120.90 Mn |
| Jun 30, 2021 | 127.28 Mn |
| Mar 31, 2021 | 127.48 Mn |
| Dec 31, 2020 | 42.73 Mn |
| Jun 30, 2020 | 39.48 Mn |
| Mar 31, 2020 | 39.57 Mn |
| Dec 31, 2019 | 62.75 Mn |
| Dec 31, 2018 | 67.40 Mn |